Abstract:Exosomes are nanoscale-sized membrane vesicles released by cells into their extracellular milieu. Within these nanovesicles reside a multitude of bioactive molecules, which orchestrate essential biological processes, including cell differentiation, proliferation, and survival, in the recipient cells. These bioactive properties of exosomes render them a promising choice for therapeutic use in the realm of tissue regeneration and repair. Exosomes possess notable positive attributes, including a high bioavailability, inherent safety, and stability, as well as the capacity to be functionalized so that drugs or biological agents can be encapsulated within them or to have their surface modified with ligands and receptors to imbue them with selective cell or tissue targeting. Remarkably, their small size and capacity for receptor-mediated transcytosis enable exosomes to cross the blood-brain barrier (BBB) and access the central nervous system (CNS). Unlike cell-based therapies, exosomes present fewer ethical constraints in their collection and direct use as a therapeutic approach in the human body. These advantageous qualities underscore the vast potential of exosomes as a treatment option for neurological injuries and diseases, setting them apart from other cell-based biological agents. Considering the therapeutic potential of exosomes, the current review seeks to specifically examine an area of investigation that encompasses the development of Schwann cell (SC)-derived exosomal vesicles (SCEVs) as an approach to spinal cord injury (SCI) protection and repair. SCs, the myelinating glia of the peripheral nervous system, have a long history of demonstrated benefit in repair of the injured spinal cord and peripheral nerves when transplanted, including their recent advancement to clinical investigations for feasibility and safety in humans. This review delves into the potential of utilizing SCEVs as a therapy for SCI, explores promising engineering strategies to customize SCEVs for specific actions, and examines how SCEVs may offer unique clinical advantages over SC transplantation for repair of the injured spinal cord.

Mesenchymal Stem Cell-Derived Exosomes: Hope For Spinal Cord Injury Repair

Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in Spinal Cord Injury

Mesenchymal stem cell-derived exosomes: therapeutic opportunities and challenges for spinal cord injury

Bone Marrow Mesenchymal Stem Cells (bmscs) Improved Functional Recovery of Spinal Cord Injury Partly by Promoting Axonal Regeneration

Exosomes Derived from Mesenchymal Stem Cells: Therapeutic Opportunities for Spinal Cord Injury

Mesenchymal stem cell-derived exosomes as a new drug carrier for the treatment of spinal cord injury: A review

The Role of Exosomes from Mesenchymal Stem Cells in Spinal Cord Injury: A Systematic Review

Exosome-mediated repair of spinal cord injury: a promising therapeutic strategy

Stem Cell Transplantation: A Promising Therapy for Spinal Cord Injury.

Stem Cell-Derived Exosomes as a Therapeutic Option for Spinal Cord Injuries; a Systematic Review and Meta-Analysis

Exosomes as promising bioactive materials in the treatment of spinal cord injury

Therapeutic Potential of Mesenchymal Stem Cells (MSCs) and MSC-Derived Extracellular Vesicles for the Treatment of Spinal Cord Injury

Mesenchymal stem cell-derived extracellular vesicles: emerging concepts in the treatment of spinal cord injury

Schwann Cell-Derived Exosomal Vesicles: A Promising Therapy for the Injured Spinal Cord

Porous Microneedle Patch with Sustained Exosome Delivery Repairs Severe Spinal Cord Injury

Exosomes combined with biomaterials in the treatment of spinal cord injury

Multipotent Mesenchymal Stem Cell-Based Therapies for Spinal Cord Injury: Current Progress and Future Prospects

Regenerative Potential of Stem Cell-derived Extracellular Vesicles in Spinal Cord Injury (SCI)

Human Umbilical Cord Mesenchymal Stem Cells Derived Exosomes Promote Neurological Function Recovery in a Rat Spinal Cord Injury Model

Transplantation of Human Mesenchymal Stem Cell-Derived Exosomes Immobilized in An Adhesive Hydrogel for Effective Treatment of Spinal Cord Injury.

The Importance of Using Exosome-Loaded miRNA for the Treatment of Spinal Cord Injury